InvestorsHub Logo
Followers 13
Posts 306
Boards Moderated 0
Alias Born 03/02/2020

Re: powerwalker post# 110598

Tuesday, 08/25/2020 9:41:06 AM

Tuesday, August 25, 2020 9:41:06 AM

Post# of 232222
Yup. Big pharma HATES the idea of a allowing a right to use drugs that are safe but have not yet conclusively demonstrated clear and impressive efficacy. That sort of demonstration that big pharma and their buddies in the FDA want to see is very expensive and time consuming---an excellent filter for keeping potentially life saving drugs from small, new, would-be competitors (like CYDY) out of the market for longer, making it all the more difficult for them to succeed.

We need more effective therapeutics, and if something out there is safe and looks effective for some patients (like leronlimab, HCQ, convalescent plasma), why not allow patients and their doctors to make the decision for themselves? BP has a ready answer: "Because that opens the door too much to competition." And, yes, they might eloquently couch that argument in the language of "science must decide!", but what that really means is writing the rules to most advantage themselves. In the meantime, thousands upon thousands of patients die as safe and promising treatments like leronlimab flounder in a molasses-slow, BP-protecitng bureaucracy.

EUA essentially requires safety + reasonable expectation of effectiveness. Enough of the BP treacle. Get leronlimab out to the people who need it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News